Patent · US Active

Compositions and methods related to xCT antibodies

US11059901B2 · kind B2 · utility

0Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2018
Grant dateJul 13, 2021
Priority date—
Expiry dateApr 30, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/622
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Certain embodiments are directed to therapeutic compositions having an xCT specific antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.